| A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive Chemotherapy (NCT07623187) | Ipsen | 2026-11-01 |
| Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy (NCT07556913) | Ipsen | 2026-07-29 |
| A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment (NCT07585097) | Ipsen | 2026-07-10 |
| Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies (NCT07282548) | Ipsen | 2026-06-01 |
| Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC) (NCT07497724) | Ipsen | 2026-04-26 |
| A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China (NCT07588880) | Ipsen | 2026-04-16 |
| A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours (NCT07441707) | Ipsen | 2026-03-03 |
| A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows (NCT07427797) | Ipsen | 2026-02-27 |
| A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows (NCT07435428) | Ipsen | 2026-02-18 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies (NCT07213830) | Ipsen | 2026-02-06 |
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment (NCT07314164) | Ipsen | 2025-12-17 |
| A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain (NCT07191704) | Ipsen | 2025-12-08 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours (NCT07213817) | Ipsen | 2025-12-05 |
| A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea (NCT07185919) | Ipsen | 2025-10-30 |
| A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria) (NCT07049887) | Ipsen | 2025-07-16 |
| A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults (NCT06937931) | Ipsen | 2025-06-30 |
| A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment (NCT06850038) | Ipsen | 2025-04-22 |
| A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours (NCT06833008) | Ipsen | 2025-03-14 |
| A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose (NCT06908954) | Ipsen | 2025-03-14 |
| A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) (NCT06730061) | Ipsen | 2025-01-16 |
| Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma (NCT06341712) | Ipsen | 2024-11-22 |
| A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment (NCT06447168) | Ipsen | 2024-10-14 |
| A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults (NCT06625060) | Ipsen | 2024-10-10 |
| A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. (NCT06383403) | Ipsen | 2024-07-09 |
| A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly (NCT06253897) | Ipsen | 2024-05-29 |
| A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours (NCT06305247) | Ipsen | 2024-04-03 |
| CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity (NCT06245772) | Ipsen | 2023-11-16 |
| A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development (NCT06055725) | Ipsen | 2023-11-01 |
| A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults (NCT06047444) | Ipsen | 2023-10-12 |
| A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults (NCT06047457) | Ipsen | 2023-09-29 |
| Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation (NCT06258902) | Ipsen | 2023-09-28 |
| A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (NCT06016842) | Ipsen | 2023-08-31 |
| A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET (NCT05922579) | Ipsen | 2023-06-15 |
| A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy (NCT05759273) | Ipsen | 2023-04-24 |
| Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China (NCT05184231) | Ipsen | 2023-02-13 |
| A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. (NCT05627362) | Ipsen | 2022-12-29 |
| Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate (NCT05590793) | Ipsen | 2022-11-17 |
| A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults (NCT05361434) | Ipsen | 2022-09-26 |
| A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA) (NCT05546190) | Ipsen | 2022-09-20 |
| Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants (NCT05543369) | Ipsen | 2022-09-19 |
| A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France. (NCT05444933) | Ipsen | 2022-09-16 |
| Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate (NCT05458856) | Ipsen | 2022-08-30 |
| Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China (NCT05431803) | Ipsen | 2022-06-30 |
| A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas (NCT05383352) | Ipsen | 2022-05-30 |
| Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting. (NCT05224349) | Ipsen | 2022-05-09 |
| A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies. (NCT05027802) | Ipsen | 2022-03-14 |
| A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK). (NCT05169775) | Ipsen | 2022-03-02 |
| Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination (NCT04957160) | Ipsen | 2021-09-09 |
| A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty. (NCT05029622) | Ipsen | 2021-08-10 |
| A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants (NCT04970407) | Ipsen | 2021-07-06 |
| A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. (NCT04936542) | Ipsen | 2021-06-23 |
| Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs (NCT04852679) | Ipsen | 2021-05-24 |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. (NCT04752774) | Ipsen | 2021-04-29 |
| United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting (NCT04649580) | Ipsen | 2021-04-27 |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines (NCT04821089) | Ipsen | 2021-04-06 |
| Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty. (NCT04736602) | Ipsen | 2021-03-27 |
| Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer. (NCT04632199) | Ipsen | 2021-03-12 |
| Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA (NCT04446702) | Ipsen | 2021-03-05 |
| Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines. (NCT04736745) | Ipsen | 2021-02-10 |
| A Study to Review Treatment Outcomes From Treatment With Dysport® Injections in Adults for Upper and/or Lower Limb Focal Spasticity (NCT04604379) | Ipsen | 2021-02-04 |
| An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families. (NCT04665323) | Ipsen | 2021-01-18 |
| A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity. (NCT04396704) | Ipsen | 2021-01-11 |
| Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England (NCT04637204) | Ipsen | 2020-11-24 |
| Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (NCT04526665) | Ipsen | 2020-09-24 |
| Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A (NCT04340336) | Ipsen | 2020-07-21 |
| Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database. (NCT04649632) | Ipsen | 2020-04-29 |
| Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly (NCT04003519) | Ipsen | 2020-04-01 |
| Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC) (NCT04106349) | Ipsen | 2020-03-03 |
| A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment (NCT04083235) | Ipsen | 2020-02-11 |
| Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors (NCT04353765) | Ipsen | 2020-01-30 |
| Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors (NCT03945773) | Ipsen | 2020-01-08 |
| Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort (NCT04050527) | Ipsen | 2019-12-19 |
| Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice (NCT03895463) | Ipsen | 2019-08-01 |
| Spasticity and Treatment Satisfaction Among Stroke Survivors (NCT03995524) | Ipsen | 2019-07-20 |
| Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice. (NCT03947762) | Ipsen | 2019-07-03 |
| Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients (NCT03776123) | Ipsen | 2019-05-15 |
| Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) (NCT03773133) | Ipsen | 2019-05-14 |
| Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours (NCT03894540) | Ipsen | 2019-03-22 |
| Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC (NCT03699579) | Ipsen | 2019-02-22 |
| Validation of Patient Reported Outcome Measures for Use in Vulvodynia (NCT03770169) | Ipsen | 2019-02-18 |
| A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK (NCT03696407) | Ipsen | 2018-12-20 |
| Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts. (NCT03744585) | Ipsen | 2018-11-06 |
| Dysport in Post-Surgical Neuralgia (NCT03663101) | Ipsen | 2018-10-30 |
| Validation of Patient Reported Outcome Measures for Use in Hallux Valgus (NCT03846687) | Ipsen | 2018-10-30 |
| Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer (NCT03697551) | Ipsen | 2018-10-22 |
| Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment. (NCT03647878) | Ipsen | 2018-09-24 |
| Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel (NCT03562091) | Ipsen | 2018-07-20 |
| Efficacy, Safety and Tolerability of a New Bowel Cleansing Preparation (BLI800) in Adult Subjects Undergoing Colonoscopy (NCT03562884) | Ipsen | 2018-07-01 |
| Dysport in Hallux Abducto Valgus (HAV) Phase IIa (NCT03569098) | Ipsen | 2018-06-19 |
| Dysport in Vulvodynia Phase II Study (NCT03598777) | Ipsen | 2018-06-11 |
| Validation of the Spasticity Related Quality of Life Questionnaire (NCT03442660) | Ipsen | 2018-05-25 |
| Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. (NCT03525392) | Ipsen | 2018-05-03 |
| Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer (NCT03088813) | Ipsen | 2018-04-25 |
| Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma (NCT03419572) | Ipsen | 2018-04-24 |
| Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy (NCT03516110) | Ipsen | 2018-03-09 |
| Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function (NCT03442725) | Ipsen | 2018-02-09 |
| Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy (NCT03008460) | Ipsen | 2017-10-15 |
| To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) (NCT03220217) | Ipsen | 2017-09-26 |